Download this free whitepaper to learn more.
This resource provides a comprehensive overview of the challenges and solutions associated with technology transfer for antibody-drug conjugate (ADC) drug product manufacturing. We explore:
- Why ADC developers increasingly rely on contract development and manufacturing organizations (CDMOs) due to high capital requirements and specialized expertise
- How to ensure your organization has the right support across drug substance and drug product, from early development to large-scale commercial manufacturing
- Systematic, holistic strategies for driving cross-functional collaboration, robust project management, and clear communication
- Approaches for ensuring operator safety, product quality, and efficient use of valuable ADC materials
- Real-world insights into gap analysis, risk mitigation, and regulatory documentation to minimize delays and maximize successful outcomes
Don’t miss key insights for optimizing tech transfer and manufacturing outcomes in a highly regulated, rapidly evolving field. Access today!
Offered Free by: Lonza
See All Resources from: Lonza
